Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Neoplasms 5Breast Neoplasms 3Neoplasm Metastasis 2Leukemia, B-Cell 2Urinary Bladder Neoplasms 1Polycystic Ovary Syndrome 1Parathyroid Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neuroblastoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Leukemia 1Hyperparathyroidism, Primary 1Head and Neck Neoplasms 1Diabetes Mellitus 1Carcinoma, Renal Cell 1Carcinoma 1Biliary Tract Neoplasms 1Adenocarcinoma of Lung 1

Interventions

ofatumumab 10Cyclophosphamide 6fludarabine 5ibrutinib 4fludarabine phosphate 4Bortezomib 3Tablets 2Chlorambucil 2tirabrutinib 1pegaspargase 1nelarabine 1immunotoxin HA22 1bempegaldesleukin 1Whole-Body Irradiation 1Vincristine 1Panobinostat 1Observation 1Nivolumab 1Mitoxantrone 1Methotrexate 1Mesna 1Mercaptopurine 1Magnetic Resonance Imaging 1MLN 8237 1Lenalidomide 1KW-2478 1Hsp90 inhibitor KU757 1Etoposide 1Electrocardiography 1Echocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Leukemia, B-Cell × Tablets × Clear all
NCT00748189 2019-06-25

COMPLEMENT 1

Novartis

Phase 3 Terminated
447 enrolled 32 charts
LymphoidOther hematologic neoplasm

Neoplasms, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01563055 2015-08-10

A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia

GlaxoSmithKline

Phase 2 Completed
10 enrolled 52 charts
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡